News Roswell Park Presents ‘Highly Encouraging’ Phase 2A Results on SurVaxM Immunotherapy for Glioblastoma
News From ASCO 2022: Brentuximab Vedotin and Chemotherapy an Effective Treatment for Hodgkin Lymphoma
News Roswell Park Researchers Identify Molecular ‘Glue’ That Sticks to and Degrades a Cancer-Causing Protein
News Roswell Park Team Shows Dendritic-Cell Vaccines Can Be Paired With Standard Therapy for Breast Cancer
News Roswell Park Experts Share Insights on Diagnosis and Treatment of Head/Neck Cancers at AHNS 2021